Todd Philip Boylan

Todd concentrates his practice in the areas of financial and strategic mergers and acquisitions, including the structuring and negotiation of stock and asset acquisitions and dispositions, mergers, joint ventures, and strategic alliance arrangements. He represents private equity, venture capital funds, and emerging companies in matters ranging from formation up to and through venture financing and exit transactions. Todd has nuanced industry experience in health care, life sciences, and technology and software, among others.

In addition to his transaction-based practice, Todd regularly represents and advises U.S. companies in the life sciences, technology, and food and beverage industries on day-to-day legal issues, including equity compensation, general corporate matters, and in connection with licensing and commercialization agreements.

• Represented a southern California-based contract manufacturing organization in its sale to a private equity fund.
• Represented a bi-coastal contract research organization in its strategic sale to a Chinese multinational company.
• Represented a Missouri-based pre-clinical laboratory in its sale to a private equity-backed CRO platform.
• Represented a privately held behavioral health company in connection with an auction-based sale process to a private equity fund.
• Represented a late-stage life sciences company in a venture backed offering of private securities.
• Represented a nonprofit charitable organization in connection with a nonprofit M&A transaction by an acquirer with more than $350 million in assets.
• Represents numerous emerging companies in connection with seed and/or venture investments in the technology and food and beverage spaces.
• Represented a life sciences company in connection with a strategic add-on acquisition of a contract research organization.
• Represented a private equity fund successfully winning an auction-based sale process and closing a platform acquisition of a manufacturer of machinery, followed by representation of portfolio company in subsequent add-ons.
• Represented a private equity fund successfully selling a platform enterprise through an auction-based sale process, with retention of representation and warranty insurance.
• Represented a national insurance broker in connection with multiple stock and asset acquisitions of regional insurance agencies.
• Represented a software company in connection with its merger with and into a private equity backed strategic acquirer.
• Represented a private equity fund in its acquisition of multiple software companies having numerous foreign operating subsidiaries.
• Represented a cable communications business in serial acquisitions of regional cable systems.
• Represented an emerging company engaged in software application development in its first venture “seed” financing.
• Represented a publicly traded health care commercialization company in its acquisition of a pharmaceutical e-marketing business.
• Represented the shareholders of a pharmaceutical service provider in the sale of the business to a private equity fund.
• Represented a private equity backed strategic buyer of foreign and domestic contract research organizations.
• Represented a group of wealthy individuals in their formation of a limited liability company and subsequent financing and asset acquisition of a financially distressed health and fitness business.
• Advised in the formation of venture capital backed special purposes vehicles and subsequent representation in connection with Series A investments.
• Represented a national software and consulting company in an acquisition of a California-based provider of network diagnostic imaging and electrodiagnostic services.
• Represented a private equity fund in its majority investment in a home products company with operations in the U.S. and China.
• Represented several recreational clubs located on the Marcellus Shale in their reorganization into separate for-profit corporations and recreational clubs as well as the related commercial arrangements of the shareholders of such corporations.

• Legal 500 United States for M&A/Corporate and Commercial: Private Equity Buyouts: Middle-Market (Up to $500M) (2024-2025)